Virpax Pharmaceuticals (VRPX) Stock Forecast & Price Target

$0.76

0.00 (0.00%)

(As of 09/18/2024 ET)

Virpax Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 1 Analyst Ratings

Based on 1 Wall Street analysts who have issued ratings for Virpax Pharmaceuticals in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for VRPX.

Consensus Price Target

$3.00
296.83% Upside

High Forecast	$3.00
Average Forecast	$3.00
Low Forecast	$3.00

According to the 1 analysts' twelve-month price targets for Virpax Pharmaceuticals, the average price target is $3.00. The highest price target for VRPX is $3.00, while the lowest price target for VRPX is $3.00. The average price target represents a forecasted upside of 296.83% from the current price of $0.76.

Type	Current Forecast 9/19/23 to 9/18/24	1 Month Ago 8/20/23 to 8/19/24	3 Months Ago 6/21/23 to 6/20/24	1 Year Ago 9/19/22 to 9/19/23
Consensus Rating	Buy	Buy	Hold	N/A
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	1 Buy rating(s)	1 Buy rating(s)	0 Buy rating(s)	N/A
Hold	0 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$3.00	$3.00	N/A	N/A
Forecasted Upside	296.83% Upside	67.60% Upside	N/A	N/A

War on Elon Escalates… (Ad)

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

VRPX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

VRPX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Virpax Pharmaceuticals Stock vs. The Competition

Type	Virpax Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.77	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	297.35% Upside	1,003.17% Upside	7.61% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
7/19/2024	Maxim Group 5 of 5 stars	N. Rahman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$3.00	+67.60%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:47 PM ET.

VRPX Forecast - Frequently Asked Questions

What is Virpax Pharmaceuticals' forecast for 2024?: According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Virpax Pharmaceuticals is $3.00, with a high forecast of $3.00 and a low forecast of $3.00.
Should I buy or sell Virpax Pharmaceuticals stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Virpax Pharmaceuticals in the last year. There is currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" VRPX shares.
Does Virpax Pharmaceuticals's stock price have much upside?: According to analysts, Virpax Pharmaceuticals's stock has a predicted upside of 67.60% based on their 12-month stock forecasts.
Has Virpax Pharmaceuticals been upgraded by Wall Street analysts recently?: Over the previous 90 days, Virpax Pharmaceuticals's stock had 1 upgrade by analysts.
What analysts cover Virpax Pharmaceuticals?: Virpax Pharmaceuticals has been rated by research analysts at Maxim Group in the past 90 days.
Do Wall Street analysts like Virpax Pharmaceuticals more than its competitors?: Analysts like Virpax Pharmaceuticals more than other "medical" companies. The consensus rating for Virpax Pharmaceuticals is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how VRPX compares to other companies.